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Why	has	the	US	opioid	crisis	not	spread	to	the	UK?
Thank	the	NHS
The	US	is	currently	experiencing	an	epidemic	of	opioid	use	–	a	crisis	which	has	yet	to
cross	the	Atlantic	to	the	United	Kingdom.	But	why	has	opioid	use	reached	crisis	point	in
the	US	but	not	in	the	UK?	Diarmuid	Denneny	and	Silvie	Cooper	argue	that	the	US	crisis
has	its	roots	in	the	promotion	of	opioids	for	chronic	pain	management	more	than	20	years
ago	which	led	to	a	culture	of	attempting	to	end	chronic	pain	rather	than	to	manage	it.	The
National	Health	Service	in	the	UK,	by	contrast,	made	pain	management	services
universally	accessible	and	offers	pain-management	strategies	beyond	opioids.
The	UK	has	a	habit	of	following	US	trends,	and	the	much	talked	about	opioid	crisis	may	be	no	exception.	However,
health	care	differences	between	both	countries	nations	may	mean	the	UK	may	be	able	to	avoid	the	same
catastrophic	consequences.
To	understand	where	the	opioid	problem	has	come	from,	we	need	to	talk	about	pain
Pain	is	an	unpleasant	experience	that	most	can	relate	to.	Pain	ranges	from	acute	to	chronic	experience.	Acute	pain
is	usually	short	lived,	lasting	less	than	three	months,	which	can	be	how	long	it	takes	for	most	to	fully	recover	from
serious	injuries	and	illnesses.	The	causes	of	acute	pain	can	often	be	easily	identified;	for	instance,	in	the	case	of	a
broken	arm,	a	compacted	wisdom	tooth,	or	appendicitis.	In	contrast,	chronic,	or	persistent,	pain	is	pain	that	lasts
longer	than	three	months.	Chronic	pain	can	result	from	injury	or	illness,	but	the	main	difference	is	that	chronic	pain
persists	even	when	the	original	cause	for	the	pain	has	resolved	(if	it	was	possible	to	identify	a	cause	in	the	first
place).		Chronic	pain	is	therefore	now	recognised	as	a	long-term	condition	in	its	own	right.
The	US	situation	
Medical	treatments	are	much	better	at	dealing	with	acute	pain	than	chronic	pain,	partly	because	with	acute	pain,
there	is	often	(although	not	always)	an	easily	identifiable	“target”	for	treatment.	Opioids,	for	instance,	are	usually
helpful	when	used	for	acute	pain,	especially	around	the	time	of	surgery,	but	become	less	effective	when	used	for
chronic	pain,	have	many	side	effects	if	taken	regularly	for	long	periods	of	time	including	actually	increasing	pain,	and
can	be	lethal	at	high	doses.	The	use	of	opioids	for	managing	chronic	pain	is	a	relatively	recent	phenomenon	and
started	as	an	attempt	to	try	to	reduce	the	distress	of	chronic	pain.
As	early	as	1995,	concerns	about	the	management	of	pain	led	to	The	5th	vital	sign	initiative	from	the	American	Pain
Society.	In	acknowledging	that	pain	was	inadequately	managed,	and	in	attempting	to	address	the	issue	and	make
more	treatments	available	to	more	patients	through	this	initiative,	there	was	a	subsequent	increase	in	the	prescription
of	opioids	for	chronic	pain	with	support	from	pharmaceutical	companies,	who	were	keen	to	increase	their	share	of	the
market.	Sales	of	prescription	opioids	in	the	US	nearly	quadrupled	between	1999	and	2014.	Although	the	intentions	of
the	initiative	might	have	been	admirable,	the	devastating	consequences	are	only	now	being	realised.
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Americans	are	less	than	5	per	cent	of	the	world’s	population;	but	they	consume	80	per	cent	of	the	world’s	opioid
supply.	The	factors	driving	opioid-related	mortality	in	North	America	are	numerous	and	can	be	broadly	categorised
into	prescriber	behaviour,	characteristics	and	behaviour	of	patients,	and	environmental	and	systematic	determinants.
With	growing	awareness	of	the	problem	and	increasing	restrictions	on	prescription	of	opioids	many	patients	have
been	forced	to	seek	alternative	means	to	obtain	them.	Of	those	who	use	opioids	intravenously	(heroin	or	similar
drugs),	80	per	cent	began	with	a	prescription	opioid.	The	US	Centre	for	Disease	Control	(CDC)	has	estimated	that	60
000	Americans	died	from	opioid	overdoses	between	2016	and	2017,	more	than	those	killed	in	motor	vehicle
accidents.
So	what’s	happening	in	the	UK?	
Worryingly	there	are	signs	of	a	similar	trend	as	long-term	opioid	prescribing	is	increasing	in	the	UK	despite	what	we
are	learning	from	the	US.	However,	there	are	differences	between	our	two	systems	that	may	protect	us	from	the
crisis	being	experienced	there.
The	NHS	and	joined	up	care	
The	NHS	is	not	without	its	problems	but	unlike	the	US	we	are	lucky	to	have	a	service,	free	at	the	point	of	care,	and
set	up	so	that	“doctor	shopping”	is	difficult.	Unlike	the	US,	universally	accessible	pain	management	services	are
available	on	the	NHS	and	provide	support	for	this	group	of	patients.	One	response	to	the	crisis	in	the	US	was	to
abruptly	discontinue	prescriptions	of	opioid	medications	to	patients.	This	is	not	a	common	practice	in	the	UK	and
there	is	ongoing	research	into	ways	to	support	this	group	of	patients	to	optimise	their	medication,	support	primary
care	management,	and	learn	other	pain	self-management	strategies.
What	is	being	done	about	this	in	the	US	and	the	UK?	
Chronic	pain	requires	a	different	approach	to	be	taken.	Patients	and	healthcare	professionals,	and	the	healthcare
system	they	interact	in,	need	to	be	able	to	accept	that	chronic	pain	is	an	ongoing	condition	that	needs	to	be
managed,	rather	than	an	acute	issue	that	can	be	treated	and	“cured”.	This	is	no	easy	request	and	many,	including
healthcare	providers,	struggle	to	accept	this.
Successful	chronic	pain	management	requires	the	development	of	a	relationship	between	the	patient	and	provider
that	is	collaborative	rather	than	simply	dispensing	treatments.	It	may	include	adjusting,	and	when	possible	reducing,
a	combination	of	suitable	medications,	changes	to	behaviour	and	lifestyles	to	facilitate	self-managing	the	symptoms
with	support	from	physical	therapists	and	clinical	health	psychologists.
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In	response	to	the	mounting	prescription	overdose	crisis,	the	US	Centre	for	Disease	Control	has	taken	a	positive
stance	and	disseminated	guidelines	that	favor	chronic	pain	management	which	emphasises	treatments	such	as
exercise	therapy,	nonsteroidal	inflammatory	drugs	and	other	treatments	and	approaches	that	are	evidence-based,
effective	and	present	far	lower	risks	for	chronic	pain	patients	than	opioids.	Initiatives	to	support	primary	care
healthcare	professionals	regarding	how	to	advise	and	support	this	group	of	patients	are	being	developed	and	there
are	encouraging	signs	of	changing	behaviour	from	healthcare	providers	and	growing	awareness	of	the	issues	by	the
general	public.
As	with	the	US,	one	answer	lies	in	better	management	in	primary	care	in	the	UK,	with	increasing	awareness	of	the
problem	and	emphasis	on	changing	prescribing	behaviour.	An	unintended	outcome	of	the	5th	vital	sign	initiative	has
been	the	expectation	that	pain	is	something	that	can	always	be	avoided,	which	we	know	to	be	untrue.	Health	care
providers	can	give	patients	realistic	expectations	of	what	is	achievable,	particularly	with	pain.	The	initiation	of
medication	should	be	subject	to	review	and	relief	from	pain	should	not	be	an	adequate	outcome	measure	on	its	own.
The	development	of	roles	for	health	care	professionals	other	than	doctors	may	also	provide	a	unique	opportunity	to
assist	with	pain	management.	Prescribing	rights	for	Physiotherapists	and	Nurses	has	been	in	place	in	the	UK	since
2005	and	physiotherapists	may	be	ideally	positioned	to	support,	advise,	and	optimise	medication	for	people	at	all
stages	of	their	health	journey,	from	the	early	rehab	phase	when	patients	are	being	discharged	from	hospital	on
opioids,	perhaps	following	hip	or	knee	surgery.	They	are	also	well	positioned	to	support	longer	term	chronic	pain
patients	in	developing	self-management	strategies	that	are	informed	by	evidence,	such	as	gradual	increases	in
movement	and	exercise,	and	allow	them	to	rely	less	on	medication	as	they	continue	to	cope	with	their	persistent
pain.
Despite	advances	in	research	and	treatment,	it	is	now	well	accepted	that,	for	many	people	with	chronic	pain	there	is
no	cure,	however,	our	understanding	of	how	best	to	manage	it	has	come	a	long	way	in	the	last	20	years.	It	is
possible	to	live	well	again,	reducing	the	impact	of	symptoms	and	improving	function,	without	having	to	rely	on
opioids;	it	just	might	involve	thinking	laterally	and	joining	forces	to	learn	from	best	practice	on	both	sides	of	the	pond.
Please	read	our	comments	policy	before	commenting.										
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